Paper
0
Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC)
Authors
Pau Abrisqueta,Eva González-Barca
Eduardo Ríos,Margarita Mata,Luis‐Felipe Casado,Rafael Andreu,José‐Ángel Hernández‐Rivas,María Terol,Almudena Navarro‐Bailón,María‐Belén Vídriales,Javier Serna,A. Ramirez,Carmén Ballester,Carol Moreno,José García‐Marco,Raúl Córdoba,Luis-Felipe Casado,Douglas Easton,Francesc Bosch,Christelle Ferrà,Julio Delgado,María‐Belén Vidriales,Patricia Baltasar,Ángel Ramírez
+22 authors
,Luís CasadoJournal
Published
May 25, 2024
Show more
Save
Tip0
TipSave